67 results
8-K
FATE
Fate Therapeutics Inc
30 Jan 15
Departure of Directors or Certain Officers
12:00am
opportunity outside of the hematopoietic cell therapeutics field. The Company has initiated efforts to recruit a successor to Dr. Multani’s role
424B3
FATE
Fate Therapeutics Inc
2 May 24
Prospectus supplement
4:02pm
and commercialize our product candidates without infringing the proprietary rights of third parties;
our ability to recruit and retain key personnel
10-Q
2013 Q3
FATE
Fate Therapeutics Inc
13 Nov 13
Quarterly report
12:00am
are and will be conducted;
· the ability to identify, solicit and recruit a sufficient number of patients;
· the ability to monitor patients adequately … :
· the results of our preclinical studies and clinical trials;
· our ability to recruit and enroll patients for our clinical trials;
· the efficacy, safety
424B3
nw9ll9rez7nmpjrey
25 Jan 17
Prospectus supplement
12:00am
S-3ASR
clelo6ck5 8rqk
4 Nov 21
Automatic shelf registration
4:56pm
S-3ASR
uiixgr 5twrkyl
21 Nov 18
Automatic shelf registration
4:06pm
424B5
k6z2w1xljx934
11 Sep 19
Prospectus supplement for primary offering
4:08pm
424B5
bm2aal6k 82an
12 Sep 19
Prospectus supplement for primary offering
9:25pm
424B5
endhv
20 Mar 24
Prospectus supplement for primary offering
5:30pm
424B5
l40c9jgltlcrs53nuazf
21 Sep 18
Prospectus supplement for primary offering
4:41pm
424B5
ufrj5r93zswi15xcg
20 Sep 18
Prospectus supplement for primary offering
4:24pm